CytoDyn (CYDY) FCF Margin (2021 - 2022)
CytoDyn's FCF Margin was -17776.47% in fiscal Q4 2022 (quarter ended May 31, 2022).
Powered by 
Analysis
CytoDyn (CYDY) FCF Margin (2021 - 2022) Analysis & Trends
For FY2022 (ended May 31, 2022), FCF Margin at CytoDyn came in at -25907.67%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.61 Bn | 1,103.20 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 616.25 Bn | 534.77 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 501.45 Bn | 474.56 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 261.44 Bn | 235.12 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 235.87 Bn | 191.27 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 169.40 Bn | 116.05 Bn | 10.94 Bn | 2.01% |
| 10 | CytoDyn | 341.69 Mn | 292.84 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2022 | -17,776.47% |
| Nov 30, 2021 | -12,842.67% |
| Aug 31, 2021 | -77,436.59% |
API Access
CytoDyn FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();